Canada Markets closed

IBEX Technologies Inc. (IBT.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.4500+0.0250 (+5.88%)
At close: 11:00AM EDT

IBEX Technologies Inc.

5485 ParE Street
Suite 100
Montreal, QC H4P 1P7
Canada

https://www.ibex.ca

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Paul BaehrPres, CEO & Chairman339.4kN/A1943
Belinda Franco C.A., CPACFO, VP of Fin. & Admin. and Sec.187.61kN/AN/A
Mahendra Kumar PallapothuVP of Operations327.09kN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, the United Kingdom, Germany, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was founded in 1986 and is based in Montreal, Canada.

Corporate Governance

IBEX Technologies Inc.’s ISS Governance QualityScore as of May 1, 2022 is 1. The pillar scores are Audit: 10; Board: 1; Shareholder Rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.